Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
ADCC, ADCP, AEs, agnostic, artificial, assay, attention, bivalent, carcinoma, cellular, cytotoxicity, de, delisting, depreciation, divergent, dividendbelasting, downstream, driven, Eerste, ESMO, feedback, fold, highest, HNSCC, House, hybrid, inadequacy, Kamer, mediated, mismatch, neck, op, parliament, petosemtamab, scarcity, Secretary, Senate, Tweede, vivo, Wet, withholding, zenucutuzumab
Removed:
measured, presidential, Regeneron, rulemaking, TriclonicsTM
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view